Editor's Choice

Debate recap: Bird Flu Research

Two pathologists dissect a swan in the Danish Food Research Center in Aarhus, Jutland, February 16, 2006. Europe began locking up its one-billion-strong chicken flock on Wednesday after the deadly bird flu virus was found in two more countries on the continent, dealing another blow to battered poultry producers. Germany and Austria are the latest EU countries to report the discovery of dead swans infected with the H5N1 strain of avian influenza, which has spread from Asia to Africa, killed 91 people and led to the destruction of millions of birds. NORWAY OUT DENMARK OUT SWEDEN OUT NO THIRD PARTY SALES REUTERS/Henning Bagger/Scanpix

Dangerous information on a deadly virus

A call to censor scientific research on the deadly bird flu virus has global health officials debating whether such studies are worth the risk. Read our recap of a Harvard School of Public Health discussion on this subject, presented in collaboration with Reuters.  Learn More 

Diabetes to exact huge costs on poor countries

Related Topics

A doctor prepares a shot for a diabetic patient in Havana, Cuba on November 15, 2007. REUTERS/Claudia Daut

A doctor prepares a shot for a diabetic patient in Havana, Cuba on November 15, 2007.

Credit: Reuters/Claudia Daut

HONG KONG | Tue Feb 23, 2010 10:34am EST

HONG KONG (Reuters) - Diabetes and its complications -- such as strokes and heart disease -- will place an enormous financial burden on poorer countries in years to come, researchers warned in a report published Tuesday.

"Diabetes is moving from being a disease of developed countries to a disease in developing countries like India and China, and this could put pressure on healthcare systems through rising healthcare costs," said Philip Clarke, associate professor at University of Sydney's School of Public Health.

Clarke and his colleagues examined records of 11,140 patients with severe diabetes in 20 countries, including the complications they suffered, money spent and length of hospital stays; and they found diabetes hit healthcare costs more severely in poorer countries.

"Patients in Asia and Eastern Europe had higher incidence of some events (eg. stroke) than patients in established market economies, lower rates of hospitalization and longer lengths of stay," according to the report.

While average per capita spending on healthcare in China was around $216 (international dollars) a year, health expenditure for a diabetic who ends up with stroke would be 10 times more, or $2,166, according to the study, which was published in the latest issue of PLoS Medicine.

International dollar is the equivalent of the US dollar but adjusted for purchasing power across countries.

"We know there are efficient ways of reducing these rates of complications. If you can stop people having strokes through blood pressure control, you can clearly reduce these patients' healthcare costs," Clarke told Reuters by telephone.

Nearly 250 million people worldwide have diabetes and this number is increasing, with three quarters of all people with diabetes living in the developing world.

The 20 countries involved in the study are China, India, Malaysia, the Philippines, the Czech Republic, Estonia, Hungary, Lithuania, Poland, Russia, Slovakia, Australia, Canada, France, Germany, Ireland, Italy, the Netherlands, New Zealand and Britain.

The paper is available here%3Adoi%2F10.1371%2Fjourn

al.pmed.1000236 (Reporting by Tan Ee Lyn; Editing by David Fox)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
logic wrote:
Education is the key.

Feb 23, 2010 10:18am EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.